1. P078 A genetic variant of IL-32 is associated with the ex vivo cytokine production of ANTI-TNF treated pbmcs isolated from rheumatoid arthritis patients. (21st February 2018) Authors: Popa, C; Damen, M; Schraa, K; Tweehuysen, L; den Broeder, A; Netea, M; Joosten, L Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 1 Page Start: A46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P159/O30 OLT1177™, an oral NLRP3 inflammasome inhibitor, inhibits acute joint inflammation and circulating IL 1β during gout flares in humans. (March 2019) Authors: Klück, V; Janssen, M; Jansen, TL; Tengesdal, IW; Schraa, K; Skouras, DB; Marchetti, C; Dinarello, CA; Joosten, LA Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 1 Page Start: A69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗